Advances in HER2-targeted therapies have improved the survival of patients with HER2- positive breast cancer. The standard-of-care treatment for localized disease has been …
A Janesick, R Shelansky, AD Gottscho… - Nature …, 2023 - nature.com
Single-cell and spatial technologies that profile gene expression across a whole tissue are revolutionizing the resolution of molecular states in clinical samples. Current commercially …
B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
Introduction Extensive research is directed to uncover new biomarkers capable to stratify breast cancer patients into clinically relevant cohorts. However, the overall performance …
Q Xu, Z Ma, HE Na, W Duan - Computers in Biology and Medicine, 2023 - Elsevier
Deep learning architecture with convolutional neural network achieves outstanding success in the field of computer vision. Where U-Net has made a great breakthrough in biomedical …
Single-cell analyses have revealed extensive heterogeneity between and within human tumours,,–, but complex single-cell phenotypes and their spatial context are not at present …
Purpose To provide current recommendations about fertility preservation for adults and children with cancer. Methods A systematic review of the literature published from January …
Breast cancer is a heterogeneous disease. Tumor cells and associated healthy cells form ecosystems that determine disease progression and response to therapy. To characterize …
N Masuda, SJ Lee, S Ohtani, YH Im… - … England Journal of …, 2017 - Mass Medical Soc
Background Patients who have residual invasive carcinoma after the receipt of neoadjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)–negative breast cancer …